2022
Integrated physiology of the exocrine and endocrine compartments in pancreatic diseases.
Mastracci, T.L., Apte, M., Amundadottir, L.T., Alvarsson, A., Artandi, S., Bellin, M.D., Bernal-Mizrachi, E., Caicedo, A., Campbell-Thompson, M., Cruz-Monserrate, Z., El Ouaamari, A., Gaulton, K.J., Geisz, A., Goodarzi, M.O., Hara, M., Hull-Meichle, R.L., Kleger, A., Klein, A.P., Kopp, J.L., Kulkarni, R.N., Muzumdar, M.D., Naren, A.P., Oakes, S.A., Olesen, S.S., Phelps, E.A., Powers, A.C., Stabler, C.L., Tirkes, T., Whitcomb, D.C., Yadav, D., Yong, J., Zaghloul, N.A., Sander, M. and Pandol, S.J.
Pancreas 51
(9): 1061-1073.
1 October 2022
2016
Second-line treatment in pancreatic cancer patients: Who profits? Results from the CONKO study group.
Sinn, M., Daelken, L., Striefler, J.K., Bischoff, S., Schweitzer, N., Pelzer, U., Doerken, B., Riess, H. and Stieler, J.M.
Pancreas 45
(4): 601-605.
April 2016
This list was generated on Sat Dec 21 16:37:26 2024 UTC.